FIELD: medicine, gynecology. SUBSTANCE: for prevention of conception in women of genital age melatonin at daily dose 2-1 000 mg/70 kg body mass or compositions containing melatonin mixture at amount 2-1 000 mg and progestogen at amount 7.5-2 500 mg, or a mixture of melatonin and estrogen at amount 2-100 mg, or a mixture of melatonin, progestogen and estrogen are given by different schedule. Invention proposes preparation sets at different combination for prevention of conception in women. EFFECT: enhanced effectiveness of ovulation suppression, absence of negative adverse effects. 30 cl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR REDUCING RISK TO ACQUIRE MAMMARY GLAND CARCINOMA | 1992 |
|
RU2067001C1 |
METHOD FOR TREATING STERILITY | 2000 |
|
RU2226395C2 |
METHOD OF PREVENTING AND DELAYING FECUNDATION | 1994 |
|
RU2139055C1 |
AGENT FOR HORMONAL CONTRACEPTION THAT INHIBITS OVULATION | 1992 |
|
RU2091069C1 |
ESTROGEN (PROGESTIN)-ANITOPROGESTIN METHOD OF PERORAL CONTRACEPTION AND MENSTRUATION CONTROL, PHARMACEUTICAL COMPOSITION, AND ASSEMBLY OF DRUGS | 1993 |
|
RU2127112C1 |
THREE-PHASE ORAL CONTRACEPTIVE | 1999 |
|
RU2225207C2 |
SCHEME OF ESTROGEN REPLENISHMENT | 2003 |
|
RU2340345C2 |
ORAL CONTRACEPTIVES FOR PREVENTION PREGNANCY AND REDUCTION OF PREMENSTRUAL SYMPTOMATOLOGY | 2002 |
|
RU2351339C2 |
APPLICATION OF ANTIPROGESTAGENS IN COMBINED THERAPY | 2000 |
|
RU2234321C2 |
RECOVERY OF TONIC SECRETION OF OVARIAN ESTROGEN FOR PROLONGED THERAPEUTIC SCHEMES | 1995 |
|
RU2181598C2 |
Authors
Dates
1998-07-10—Published
1988-03-22—Filed